Can Nitazoxanide and/or other anti‐viral medications be a solution to long COVID? Case report with a brief literature review

KEY CLINICAL MESSAGE: Findings here imply lingering of virus, SARS‐CoV‐2, in the body for months. Thus, Nitazoxanide and/or other anti‐viral medications might be potential options to combat long COVID. This could transform treatment for long COVID patients globally. ABSTRACT: Long COVID or post‐acut...

Descripción completa

Detalles Bibliográficos
Autor principal: Stewart, Denise D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654558/
https://www.ncbi.nlm.nih.gov/pubmed/38028066
http://dx.doi.org/10.1002/ccr3.8162
_version_ 1785147859140608000
author Stewart, Denise D.
author_facet Stewart, Denise D.
author_sort Stewart, Denise D.
collection PubMed
description KEY CLINICAL MESSAGE: Findings here imply lingering of virus, SARS‐CoV‐2, in the body for months. Thus, Nitazoxanide and/or other anti‐viral medications might be potential options to combat long COVID. This could transform treatment for long COVID patients globally. ABSTRACT: Long COVID or post‐acute sequelae of COVID‐19 (PASC) continues to affect many people even after a relatively mild acute illness. Underlying causes of PASC are poorly understood. There is no particular treatment or management program developed yet. Thus, the possibility of well‐known, safe anti‐viral medications use against PASC is proposed here.
format Online
Article
Text
id pubmed-10654558
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106545582023-11-17 Can Nitazoxanide and/or other anti‐viral medications be a solution to long COVID? Case report with a brief literature review Stewart, Denise D. Clin Case Rep Case Report KEY CLINICAL MESSAGE: Findings here imply lingering of virus, SARS‐CoV‐2, in the body for months. Thus, Nitazoxanide and/or other anti‐viral medications might be potential options to combat long COVID. This could transform treatment for long COVID patients globally. ABSTRACT: Long COVID or post‐acute sequelae of COVID‐19 (PASC) continues to affect many people even after a relatively mild acute illness. Underlying causes of PASC are poorly understood. There is no particular treatment or management program developed yet. Thus, the possibility of well‐known, safe anti‐viral medications use against PASC is proposed here. John Wiley and Sons Inc. 2023-11-17 /pmc/articles/PMC10654558/ /pubmed/38028066 http://dx.doi.org/10.1002/ccr3.8162 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Stewart, Denise D.
Can Nitazoxanide and/or other anti‐viral medications be a solution to long COVID? Case report with a brief literature review
title Can Nitazoxanide and/or other anti‐viral medications be a solution to long COVID? Case report with a brief literature review
title_full Can Nitazoxanide and/or other anti‐viral medications be a solution to long COVID? Case report with a brief literature review
title_fullStr Can Nitazoxanide and/or other anti‐viral medications be a solution to long COVID? Case report with a brief literature review
title_full_unstemmed Can Nitazoxanide and/or other anti‐viral medications be a solution to long COVID? Case report with a brief literature review
title_short Can Nitazoxanide and/or other anti‐viral medications be a solution to long COVID? Case report with a brief literature review
title_sort can nitazoxanide and/or other anti‐viral medications be a solution to long covid? case report with a brief literature review
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654558/
https://www.ncbi.nlm.nih.gov/pubmed/38028066
http://dx.doi.org/10.1002/ccr3.8162
work_keys_str_mv AT stewartdenised cannitazoxanideandorotherantiviralmedicationsbeasolutiontolongcovidcasereportwithabriefliteraturereview

Ejemplares similares